Cara Therapeutics Inc (NASDAQ:CARA)

28.55
Delayed Data
As of 3:59pm ET
 +1.10 / +4.01%
Today’s Change
12.30
Today|||52-Week Range
29.65
+88.70%
Year-to-Date

Today’s Trading

Previous close27.45
Today’s open27.90
Day’s range27.21 - 28.63
Volume44,302
Average volume (3 months)756,373
Market cap$1.5B
Data as of 3:59pm ET, 04/14/2021

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,165.08%
Earnings growth (next 5 years)-66.83%
Revenue growth (last year)+579.28%
P/E ratio158.6
Price/Sales5.37
Price/Book5.85

Competitors

 Today’s
change
Today’s
% change
ALECAlector Inc+0.04+0.23%
REPLReplimune Group Inc+0.35+1.16%
TBIOTranslate Bio Inc+1.24+7.13%
SAVACassava Sciences Inc-0.38-1.05%
Data as of 4:00pm ET, 04/14/2021

Financials

Next reporting dateMay 6, 2021
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$135.1M
Annual profit (last year)$8.4M
Net profit margin6.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Stamford, Connecticut

Forecasts